SPDL1 and coronary artery disorder: Fujisue et al. (29) proved that soluble PD-L1 (sPD-L1) levels were elevated in patients with coronary artery disease, and Miyazaki et al. (30) prospectively found elevated levels of sPD-L1 increased cardiovascular risk in these patients.